Fig. 3: The overall availability of all kinds of drugs (n = 1018).
From: The availability of drugs for stable COPD treatment in China: a cross-sectional survey
A Monotherapy; B LAMA/LABA; C ICS/LABA; D ICS/LAMA/LABA; E oral drugs. SABA short-acting β2 agonist, LABA long-acting β2 agonist, SAMA short-acting antimuscarinics, LAMA long-acting antimuscarinics, ICS inhaled corticosteroids.
